150 related articles for article (PubMed ID: 19212333)
1. GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines.
Furuhata A; Murakami M; Ito H; Gao S; Yoshida K; Sobue S; Kikuchi R; Iwasaki T; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T
Leukemia; 2009 Jul; 23(7):1270-7. PubMed ID: 19212333
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
3. Distinct functions of dispersed GATA factor complexes at an endogenous gene locus.
Grass JA; Jing H; Kim SI; Martowicz ML; Pal S; Blobel GA; Bresnick EH
Mol Cell Biol; 2006 Oct; 26(19):7056-67. PubMed ID: 16980610
[TBL] [Abstract][Full Text] [Related]
4. GATA-1 transactivates the WT1 hematopoietic specific enhancer.
Wu Y; Fraizer GC; Saunders GF
J Biol Chem; 1995 Mar; 270(11):5944-9. PubMed ID: 7890725
[TBL] [Abstract][Full Text] [Related]
5. New insights into the regulation of CYP2C9 gene expression: the role of the transcription factor GATA-4.
Mwinyi J; Nekvindová J; Cavaco I; Hofmann Y; Pedersen RS; Landman E; Mkrtchian S; Ingelman-Sundberg M
Drug Metab Dispos; 2010 Mar; 38(3):415-21. PubMed ID: 19995889
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.
Patmasiriwat P; Fraizer GC; Claxton D; Kantarjian H; Saunders GF
Leukemia; 1996 Jul; 10(7):1127-33. PubMed ID: 8683991
[TBL] [Abstract][Full Text] [Related]
7. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
8. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb.
Zhang X; Xing G; Fraizer GC; Saunders GF
J Biol Chem; 1997 Nov; 272(46):29272-80. PubMed ID: 9361007
[TBL] [Abstract][Full Text] [Related]
10. GATA-binding protein 1 is a novel transcription regulator of peroxiredoxin 5 in human breast cancer cells.
Seo MJ; Liu X; Chang M; Park JH
Int J Oncol; 2012 Mar; 40(3):655-64. PubMed ID: 22020876
[TBL] [Abstract][Full Text] [Related]
11. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
[TBL] [Abstract][Full Text] [Related]
13. The GATA site-dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells.
Yang LV; Wan J; Ge Y; Fu Z; Kim SY; Fujiwara Y; Taub JW; Matherly LH; Eliason J; Li L
Leukemia; 2006 Mar; 20(3):417-25. PubMed ID: 16437149
[TBL] [Abstract][Full Text] [Related]
14. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells.
Karacay B; Chang LS
Genomics; 1999 Jul; 59(1):6-17. PubMed ID: 10395794
[TBL] [Abstract][Full Text] [Related]
15. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
16. Expression and transcriptional regulation of the human alpha1, 3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines.
Taniguchi A; Suga R; Matsumoto K
Biochem Biophys Res Commun; 2000 Jun; 273(1):370-6. PubMed ID: 10873613
[TBL] [Abstract][Full Text] [Related]
17. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
Malik KT; Wallace JI; Ivins SM; Brown KW
Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
20. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
